Differentiation between normal renal tissue and renal cell carcinoma using optical coherence tomography (OCT): a prospective human in-vivo study.

• Conditions: renal cell cancer; renal mass; 10038364; 10038365

• Registration Number: NL-OMON34505
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 34

Inclusion Criteria

> 18 yrs
solid, enhancing renal mass, suspect for malignancy
scheduled for (open or laparoscopic) nephrectomy or partial nephrectomy
signed informed consent

Exclusion Criteria

cystic renal mass

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary study outcome is the attenuation-coefficient measured by OCT of the 2<br /><br>tissue types: normal renal parenchyma and malignant (RCC) tissue. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>None</p><br>